510(k) K121842

Device
ARCHITECT HBA1C, ARCHITECT HBA1C, AND ARCHITECT HBA1C
Applicant
AXIS-SHIELD DIAGNOSTICS, LTD.
510(k) number
K121842
Product code
LCP  
Decision
Substantially Equivalent (SESE)
Decision date
2012-12-12
Date received
2012-06-25
Regulation
864.7470
Classification name
Assay, Glycosylated Hemoglobin
Medical specialty
Hematology
Review panel
Clinical Chemistry
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
CLAIRE I DORA
Address
The Technology Park Dundee GB DD2 1XA DD2 1XA

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code LCP  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K221326Nova Allegro HbA1c Assay, Nova Allegro AnalyzerNova Biomedical Corporation2024-11-22
K231465Q-Pad Test SystemQurasense2023-12-06
K214117Afinion™ HbA1c, Afinion™ 2 and Alere Afinion™ AS100 AnalyzerAbbott Diagnostics Technologies AS2023-09-27
K192987Aina HbA1c Monitoring System 2Jana Care, Inc.2020-03-26
K192369PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test KitIxensor Co, Ltd.2019-10-29
K183230OneDraw A1C Test SystemDrawbridge Health, Inc.2019-08-15
K181915PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test KitIxensor Co, Ltd.2019-04-12
K180509Quo-Test A1c SystemEkf-Diagnostic GmbH2019-02-16
K173127skyla Hi Hemoglobin A1c System (skyla Hi Analyzer and skyla Hi Hemoglobin A 1 c Reagent Kit)Skyla Corporation H.S.P.B2018-09-25
K170623ACE Hemoglobin A1c (HbA1c) ReagentAlfa Wassermann Diagnostic Technologies, LLC2018-02-27
K171650Alere Afinion HbA1c and ACR on Afinion 2 analyzerAbbott Rapid Diagnostics2017-11-21
K170147Lucica Glycated Albumin-LAsahi Kasei Pharma Corporation2017-10-12
K163633cobas HbA1c Test, cobas b 101 systemRoche Diagnostics Operations2017-07-28
K161533A1C EZ Glycohemoglobin Analysis SystemBiohermes Co., Ltd.2017-06-16
K162281CAPI 3 Hb A1c, MULTI-SYSTEM Hb A1C CAPILLARY CONTROLS (2)Sebia2017-02-17

Legacy Summary#

summary

FDA Review#

Decision Summary